Inactive Instrument
Invitae Corporation Stock
Stocks
NVTA.Q
US46185L1035
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -25.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Spirito
CEO | Chief Executive Officer | - | - |
Hoki Luk
IRC | Investor Relations Contact | - | - |
Robert Guigley
PRN | Corporate Officer/Principal | - | 05/09/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/12/23 | Tax | Compliance Officer | 17,404 | 0.0061% | ||
| 20/12/23 | Tax | Chief Technology Officer | 17,404 | 0.0061% | ||
| 13/11/23 | Free | Chief Operating Officer | 850,000 | 0.3183% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -25.00% | -25.00% | - | - | 85.95K | ||
| +1.15% | -2.81% | +55.79% | +71.12% | 65.56B | ||
| -2.64% | -1.13% | +7.82% | +88.90% | 60.41B | ||
| -1.07% | +0.30% | +22.91% | +86.76% | 55.76B | ||
| +0.48% | -2.53% | +9.73% | +121.14% | 46.98B | ||
| -2.69% | -6.38% | +19.19% | +25.79% | 43.63B | ||
| -0.70% | +4.93% | +17.77% | +45.03% | 36.7B | ||
| -2.50% | -15.73% | +135.31% | +662.73% | 36.09B | ||
| -0.77% | -2.21% | +77.27% | +57.96% | 32.9B | ||
| -0.83% | +1.98% | -38.27% | +390.98% | 26.96B | ||
| Average | -3.46% | -2.29% | +34.17% | +172.27% | 45B | |
| Weighted average by Cap. | -0.99% | -2.21% | +33.95% | +147.43% |
Employees
1,700
















